छोड़कर सामग्री पर जाएँ
Siemens#39; Q2 profit jumps 51% to Rs 456 crore due to margin expansion

Siemens#39; Q2 profit jumps 51% to Rs 456 crore due to margin expansion

Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review.

Read More

​ Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review. Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review.  Moneycontrol Latest News Read More  

Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review.

Siemens#39; Q2 profit jumps 51% to Rs 456 crore due to margin expansion

Siemens#39; Q2 profit jumps 51% to Rs 456 crore due to margin expansion

Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review.

Read More

​ Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review. Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review.  Moneycontrol Latest News Read More  

Siemens#39; results surpassed analysts#39; expectations of a net profit of around Rs 442 crore for the quarter under review.

Bulk Deals: PHI Capital Trust exits Minda Corporation, Carlyle Group offloads 2.17% stake in Piramal Pharma

Bulk Deals: PHI Capital Trust exits Minda Corporation, Carlyle Group offloads 2.17% stake in Piramal Pharma

CA Alchemy had held 20 percent stake or 23.86 crore equity shares in Piramal Pharma as of June 2023.

Read More

​ CA Alchemy had held 20 percent stake or 23.86 crore equity shares in Piramal Pharma as of June 2023. CA Alchemy had held 20 percent stake or 23.86 crore equity shares in Piramal Pharma as of June 2023.  Moneycontrol Latest News Read More  

CA Alchemy had held 20 percent stake or 23.86 crore equity shares in Piramal Pharma as of June 2023.

Tamilnadu Petroproducts logs Q1 standalone PAT of Rs 13.59 crore

Tamilnadu Petroproducts logs Q1 standalone PAT of Rs 13.59 crore

The standalone revenues during the quarter under review stood at Rs 456.50 crore, as against Rs 560.98 crore registered in the same period last year.

Read More

​ The standalone revenues during the quarter under review stood at Rs 456.50 crore, as against Rs 560.98 crore registered in the same period last year. The standalone revenues during the quarter under review stood at Rs 456.50 crore, as against Rs 560.98 crore registered in the same period last year.  Moneycontrol Latest News Read More  

The standalone revenues during the quarter under review stood at Rs 456.50 crore, as against Rs 560.98 crore registered in the same period last year.

Religare Enterprises Q1 loss narrows to Rs 6 crore

Religare Enterprises Q1 loss narrows to Rs 6 crore

Total revenues increased to Rs 8 crore during the quarter under review as against Rs 7 crore a year ago.

Read More

​ Total revenues increased to Rs 8 crore during the quarter under review as against Rs 7 crore a year ago. Total revenues increased to Rs 8 crore during the quarter under review as against Rs 7 crore a year ago.  Moneycontrol Latest News Read More  

Total revenues increased to Rs 8 crore during the quarter under review as against Rs 7 crore a year ago.

ADF Foods Q1 net profit grows 93% to Rs 14.7 crore

ADF Foods Q1 net profit grows 93% to Rs 14.7 crore

The company#39;s revenue from operations surged 15.7 percent to Rs 112.4 crore from Rs 97.2 crore in the April-June period of FY23.

Read More

​ The company#39;s revenue from operations surged 15.7 percent to Rs 112.4 crore from Rs 97.2 crore in the April-June period of FY23. The company#39;s revenue from operations surged 15.7 percent to Rs 112.4 crore from Rs 97.2 crore in the April-June period of FY23.  Moneycontrol Latest News Read More  

The company#39;s revenue from operations surged 15.7 percent to Rs 112.4 crore from Rs 97.2 crore in the April-June period of FY23.

hi_INहिन्दी